What is Zevra Therapeutics, Inc.'s net income?

Zevra Therapeutics, Inc. (ZVRA) reported net income of $37.89M in Q1 2026.

How has Zevra Therapeutics, Inc.'s net income changed year-over-year?

Zevra Therapeutics, Inc.'s net income increased by 1322.7% year-over-year, from -$3.1M to $37.89M.

What is the long-term trend for Zevra Therapeutics, Inc.'s net income?

Over 3 years (2021 to 2025), Zevra Therapeutics, Inc.'s net income has grown at a 113.5% compound annual growth rate (CAGR), from -$8.56M to $83.23M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Zevra Therapeutics, Inc. ZVRA Net Income

Net Income at other companies

BioMarin PharmaceuticalsBMRN

$105.53M-43.2%

Ultragenyx PharmaceuticalRARE

-$185M-22.5%

XER

Xeris Biopharma Holdings, Inc.XERS

$2.23M+124%

Eton Pharmaceuticals, Inc.ETON

$1.55M+199%

Theravance BiopharmaTBPH

-$4.93M+63.7%

Relay Therapeutics, Inc.RLAY

-$73.29M+4.9%

Segments

By segment

See full

Reportable Segment$37.89M+1,323%

Other financials

Income statement

See full

Revenue$36.2M+77.5%

Gross profit$34.3M+80.1%

Operating income$52.1M+1,073%

EPS (diluted)$0.60+1,100%

Balance sheet

See full

Cash & equivalents$95.6M+156%

Total debt$1.1M-98.1%

Total equity$205.8M+402%

Total assets$278.6M+61.3%

Cash flow

See full

Operating cash flow$6.1M+175%

CapEx$35.0K-64.6%

Free cash flow$6.1M+173%

Valuation

See full

Market cap$773.23M+56.4%

Enterprise value$678.78M+30.8%

P/E6.2×—

P/S6.3×-5.9×

Profitability

See full

Gross margin86.1%+7.2pp

Operating margin-103.9%-43.0pp

Net margin101.6%+60.1pp

FCF margin-75%-30.5pp

Returns & leverage

See full

Return on equity100.7%+60.3pp

Debt / equity0×-1.5×

Current ratio4.9×+1.9×

Where this comes from

Reported directly by Zevra Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zevra Therapeutics, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zevra Therapeutics, Inc.'s net income?: Zevra Therapeutics, Inc. (ZVRA) reported net income of $37.89M in Q1 2026.
How has Zevra Therapeutics, Inc.'s net income changed year-over-year?: Zevra Therapeutics, Inc.'s net income increased by 1322.7% year-over-year, from -$3.1M to $37.89M.
What is the long-term trend for Zevra Therapeutics, Inc.'s net income?: Over 3 years (2021 to 2025), Zevra Therapeutics, Inc.'s net income has grown at a 113.5% compound annual growth rate (CAGR), from -$8.56M to $83.23M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.